Hospira Recalls
257 recalls on record · June 20, 2012 to May 31, 2017 · Drugs, Medical Devices
Recalls by year
12
13
14
15
16
17
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
October 31, 2012Medical DevicesFDA
Hospira Inc. recalls Symbiq Two Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids; Hospira, Inc., Lake Fores
Hazard: The Symbiq pump touchscreen may not respond to user selection, may experience a delayed response, or may register a different value from the value selected by the user. Failure of the touchscreen to respond to user input could result in a delay in therapy or result in over delivery or under delivery of medication if the user does not confirm the programmed values on the pump's confirmation screen prior to starting the infusion.
October 31, 2012Medical DevicesFDA
Hospira Inc. recalls Symbiq One Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids; Hospira, Inc., Lake Fores
Hazard: The Symbiq pump touchscreen may not respond to user selection, may experience a delayed response, or may register a different value from the value selected by the user. Failure of the touchscreen to respond to user input could result in a delay in therapy or result in over delivery or under delivery of medication if the user does not confirm the programmed values on the pump's confirmation screen prior to starting the infusion.
October 31, 2012DrugsFDA
Hospira Inc. recalls HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-coun
Hazard: Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.
October 3, 2012DrugsFDA
Hospira Inc. recalls Propofol Injectable Emulsion, 1%, packaged in a) 20 mL Single patient infusion vial, 200 mg/20 mL (10 mg/mL), NDC 0409-4
Hazard: Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.
September 26, 2012Medical DevicesFDA
Hospira Inc. recalls Empty Evacuated Container 250 mL and 1000 mL. Empty Evacuated containers are used for mixing compatible medications o
Hazard: Embedded iron oxide glass defect which may have the potential to break off into the solution.
September 26, 2012DrugsFDA
Hospira Inc. recalls Paclitaxel Injection, 6 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospira
Hazard: The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
September 26, 2012DrugsFDA
Hospira Inc. recalls Methotrexate Injection, USP, 25 mg/mL, 40 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for
Hazard: The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
September 26, 2012DrugsFDA
Hospira Inc. recalls Cytarabine Injection, 20 mg/mL, 50 mL Single Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospi
Hazard: The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
September 26, 2012DrugsFDA
Hospira Inc. recalls Carboplatin Injection, 10 mg/mL, 45 mL Multi-Dose Vial, Rx only, antineoplastic/cytotoxic agent; Manufactured for Hospi
Hazard: The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are beig recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
September 19, 2012Medical DevicesFDA
Hospira, Inc. recalls Sterile Empty Vial and Injector (30mL PCA vial), Rx only, One/List No. 6021-03, Hospira, Inc., Lake Forest, IL 60045.
Hazard: Reports of leaking during filling and administration.
September 5, 2012DrugsFDA
Hospira Inc. recalls Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lak
Hazard: Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.
August 22, 2012DrugsFDA
Hospira Inc. recalls Carboplatin Injection, 10 mg/mL, a) 5 mL multi-dose vials (NDC 61703-339-18) (NDC 61703-360-18, NOVAPLUS), b) 45 mL mul
Hazard: Failed PH specification: The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.
August 15, 2012DrugsFDA
Hospira Inc. recalls HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-coun
Hazard: Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be overfilled and contain more than the 1 mL labeled fill volume.
August 1, 2012Medical DevicesFDA
Hospira Inc. recalls Hospira LifeShield Latex-Free 100 mL Burette Set, Convertible Pin, 77 inch with 2 Prepierced Injection Sites and Option-
Hazard: The float valve in the burette sticks to the burette wall and does not open or close properly.
July 25, 2012DrugsFDA
Hospira Inc. recalls Morphine Sulfate Injection, USP, 4mg/mL, 1 mL fill in 2.5 mL Carpuject Cartridge Unit with Luer Lock, packaged 10 Carpu
Hazard: Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL
June 27, 2012DrugsFDA
Hospira, Inc. recalls Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Ho
Hazard: Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
June 20, 2012DrugsFDA
Hospira, Inc. recalls Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials
Hazard: Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel